Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor
Authors:
- 1 April 2013
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 41 (4) , 836-843
Abstract
Incubational binding or the fraction of drug unbound in an in vitro incubation, fuinc, is an important parameter to predict or measure in the pursuit of accurate clearance predictions from in vitro data. Here we describe a method for fuinc determination directly in the hepatocyte intrinsic clearance (CLint) assay with emphasis on compounds that are actively transported into hepatocytes, hypothesizing that for such compounds the typical protocol of 1 million hepatocytes/ml systematically underestimates the maximum attainable unbound intracellular drug concentration. Using the transporter substrate atorvastatin as a test compound, incubations were performed and a mathematical model applied to describe metabolism, distribution, and binding at different hepatocyte concentrations. From these investigations it was evident that, since binding is more extensive intracellularly than in the medium, increased partitioning into the cellular volume, due to active uptake, increases the total amount of atorvastatin bound in the incubation. Consequently, a significant lowering of the hepatocyte concentration impacts the free drug concentration in the incubation and increases the observed rate of metabolism and therefore observed CLint (that is, when viewed from the media drug concentration). The applicability of the findings was tested for a series of 11 actively transported zwitterions for which standard rat hepatocyte metabolic CLint data (1 million cells/ml incubation) poorly predicted in vivo clearance (average fold error of 5.4). Using metabolic CLint determined at a lower hepatocyte concentration (0.125 million cells/ml) considerably improved clearance predictions (average fold error of 2.3).Keywords
This publication has 33 references indexed in Scilit:
- Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat HepatocytesDrug Metabolism and Disposition, 2012
- Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic ModelThe Journal of Pharmacology and Experimental Therapeutics, 2012
- The Impact of Hepatic Uptake on the Pharmacokinetics of Organic AnionsDrug Metabolism and Disposition, 2011
- Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported DrugsDrug Metabolism and Disposition, 2011
- Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro ModelDrug Metabolism and Disposition, 2008
- Functional Consequences of Active Hepatic Uptake on Cytochrome P450 Inhibition in Rat and Human HepatocytesDrug Metabolism and Disposition, 2008
- Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat HepatocytesDrug Metabolism and Disposition, 2008
- In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspectsXenobiotica, 2007
- The pivotal role of hepatocytes in drug discoveryChemico-Biological Interactions, 2006
- Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver modelXenobiotica, 2006